Adrian Kilcoyne - 12 Jan 2022 Form 4 Insider Report for HUMANIGEN, INC

Role
Chief Medical Officer
Signature
/s/ Timothy Morris, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
12 Jan 2022
Net transactions value
$0
Form type
4
Filing time
14 Jan 2022, 16:05:24 UTC
Previous filing
04 Jan 2022
Next filing
14 Mar 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HGEN Stock Option (Right to Buy) Award $0 +38,411 $0.000000 38,411 12 Jan 2022 Common Stock 38,411 $2.99 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option was granted to the Reporting Person at the direction of the Company in satisfaction of amounts earned under the Company's 2021 annual incentive plan.